BSE · EMMESSA
Emmessar Biotech & Nutrition Ltd.
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#4,455
of 5,088 stocks
▼ 471W
Peak #4,408 · 21 Sep 2026
A microcap name in Healthcare, Emmessar Biotech & Nutrition Ltd. is growing revenue at a solid clip, commands a premium earnings multiple, and posts a modest return on equity.
Market Cap
11.86 Cr
P/E Ratio
27.29
P/B Ratio
1.46
ROE
5.37%
ROCE
6.37%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 5.93 L | 9.28 L | 9.34 L | 9.17 L |
| Net Profit | 13.15 L | 3.42 L | 11.64 L | 11.40 L |
| EPS | 0.26 | 0.07 | 0.23 | 0.23 |
| Operating Profit | 16.37 L | -39.32 L | 12.91 L | 14.08 L |
Shareholding pattern
Promoter
59.53%
Public
40.47%
PUBLIC BREAKDOWN
DII
0.20%
MF (within DII)
0.05%
Individuals
38.64%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
No corporate actions on record for this stock.
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.